Expand CHRS Menu
CHRS MENU

Coherus Oncology (CHRS)'s 30-day implied volatility (IV30) was 174.4% at the close on October 21, 2026, up from 75.9% the day before, against a 52-week range of 51.5% to 169.3%. Its 20-day historical volatility was 71.2%.

Key numbers
  • 30-day implied volatility (IV30): 174.4%
  • IV30 52-week range: 51.5% to 169.3% (median 81.0%)
  • Historical volatility: 20-day 71.2%, 1-year 79.0%
  • Implied move by the nearest expiration: ±4.8%

Data as of October 21, 2026.

CHRS Implied Volatility (IV) vs Historical Volatility (HV)

Market Data Delayed 15 Minutes